StockData
Nyxoah SA logo

Nyxoah SA (NYXH) stock

NYXHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$0.86−0.04 (-4.10%)

Close on Nov 18, 2026Market cap $37.13MP/E –Yield –

Nyxoah cash

Cash and short-term investments held at the end of each period.

Nyxoah's cash was €64.12M at Jun 30, 2026. For fiscal 2025 it was €30.00M, down 12.2% from the year before. The highest annual figure on record is €135.51M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025€30.00M-12.2%
FY2024Dec 31, 2024€34.19M+58.2%
FY2023Dec 31, 2023€21.61M+20.8%
FY2022Dec 31, 2022€17.89M-86.8%
FY2021Dec 31, 2021€135.51M+46.8%
FY2020Dec 31, 2020€92.30M+1476.4%
FY2019Dec 31, 2019€5.86M-65.2%
FY2018Dec 31, 2018€16.81M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€64.12M+131.3%
Q4 FY2025Dec 31, 2025€30.00M+38.8%
Q2 FY2025Jun 30, 2025€22.73M+36.9%
Q4 FY2024Dec 31, 2024€34.19M+91.1%
Q2 FY2024Jun 30, 2024€27.72M-69.2%
Q4 FY2023Dec 31, 2023€21.61M-71.4%
Q2 FY2023Jun 30, 2023€16.60M-87.7%
Q4 FY2022Dec 31, 2022€17.89M-87.3%
Q3 FY2022Sep 30, 2022€89.88M-2.6%
Q2 FY2022Jun 30, 2022€75.60M+1191.2%
Q4 FY2021Dec 31, 2021€135.51M+706.4%
Q3 FY2021Sep 30, 2021€140.91M–
Q4 FY2020Dec 31, 2020€92.30M–
Q4 FY2019Dec 31, 2019€5.86M–
Q4 FY2018Dec 31, 2018€16.81M–

More Nyxoah figures

See a number that looks wrong?